ARCHIVES

Cancer Program Advocates, Success Overcame Powerful Negative Factors To Win Budget Fight

This article is from The Cancer Letter archive.

Vol. 05 No. 32 | August 10, 1979

Download PDF Visit The Full Archive

Related Articles

Interferon Alpha-2B Effective For Malignant Melanoma

July 27, 2001

Cytogen Corp.’s Imaging Agent ProstaScint Added to NCCN Prostate Cancer Guidelines.

March 31, 2000

Shorter Hospital Stay After Robot-Assisted Surgeries

February 27, 2009

DeVita Suggest “Overlay Consortium” as Outreach Mechanism for Southern California, Other Areas

September 28, 1984

House Committee Proposes $750 Mil. Increase For NIH, supports Bypass

May 4, 1990

Review Of NTP Could Lead To Administrative Changes

April 18, 1980